Patents by Inventor William Max Stark

William Max Stark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 3968204
    Abstract: Antibiotic A-2315 mixture, comprising microbiologically active, structurally related factors A, B, and C, produced by culturing Actinoplanes philippinensis NRRL 5462 under submerged aerobic fermentation conditions. Individual factors A, B, and C are separated and isolated by chromatographic procedures. The A-2315 antibiotics are useful in controlling the growth of cariogenic organisms, in promoting the growth of chickens, and in increasing feed-utilization efficiency in ruminants.
    Type: Grant
    Filed: April 28, 1975
    Date of Patent: July 6, 1976
    Assignee: Eli Lilly and Company
    Inventors: Robert L. Hamill, William Max Stark
  • Patent number: 3962427
    Abstract: A process for producing antibiotic nebramycin II, a component antibiotic of the multifactored antibiotic complex nebramycin, and nebramycin VII by culturing Streptomyces tenebrarius NRRL 3816, mutant strain ex Streptomyces tenebrarius ATCC 17920 in an aqueous nutrient culture medium under aerobic fermentation conditions. Nebramycin II is recovered from the filtered fermentation broth by chromatography over a cationic exchange resin and is separated from the newly discovered co-produced minor factor, nebramycin VII, by further chromatography over a cationic exchange resin.
    Type: Grant
    Filed: July 31, 1974
    Date of Patent: June 8, 1976
    Assignee: Eli Lilly and Company
    Inventor: William Max Stark